|
Staging (Pancreas, Exocrine)
|   |
|
Staging (Pancreas, Exocrine)
| |
Pathologic Staging (pTNM)
CAP Approved Gastrointestinal • Pancreas (Exocrine) 4.0.0.0
TNM Descriptors (required only if applicable) (select all that apply)
___ m (multiple primary tumors)
___ r (recurrent)
___ y (posttreatment)
Primary Tumor (pT)#
___ pTX: Primary tumor cannot be assessed
___ pT0: No evidence of primary tumor
___ pTis: Carcinoma in situ (This includes high-grade pancreatic intraepithelial neoplasia (PanIN-3), intraductal papillary mucinous neoplasm with high-grade dysplasia, intraductal tubulopapillary neoplasm with high-grade dysplasia, and mucinous cystic neoplasm with high-grade dysplasia)
___ pT1: Tumor ≤2 cm in greatest dimension
___ pT1a: Tumor ≤0.5 cm in greatest dimension
___ pT1b: Tumor >0.5 cm and <1 cm in greatest dimension
___ pT1c: Tumor 1–2 cm in greatest dimension
___ pT2: Tumor >2 cm and ≤4 cm in greatest dimension
___ pT3: Tumor >4 cm in greatest dimension
___ pT4: Tumor involves the celiac axis, superior mesenteric artery, and/or common hepatic artery
# Size of invasive component should be used for determining the T category.
Regional Lymph Nodes (pN)
___ pNX: Regional lymph nodes cannot be assessed
___ pN0: No regional lymph node metastasis
___ pN1: Metastasis in one to three regional lymph nodes
___ pN2: Metastasis in four or more regional lymph nodes
Distant Metastasis (pM) (required only if confirmed pathologically in this case)
___ pM1: Distant metastasis
Specify site(s), if known: ____________________________
Summary of changes AJCC 7th to 8th edition